Bioline RX Ltd Sponsored ADR(DE:YP2)
€1.24-0.19 (-16.22%)
DE:YP2
Bioline RX Ltd Sponsored ADR Revenue
€1.24
At close:-0.19 (-16.22%)
Bioline RX Ltd Sponsored ADR (YP2) Revenue
1 Followers
Bioline RX Ltd Sponsored ADR Revenue
Bioline RX Ltd Sponsored ADR had a revenue of 299.05K in the quarter ending Jun 30, 2026, with -37.31%. This bring the company's revenue in the last twelve months to 1.40M, Decreased 0.35%. In the fiscal year ending Dec 31, 2025, Bioline RX Ltd Sponsored ADR had annual revenue of 1.19M with -95.89% growth.
- Revenue (ttm)
- 1.40M
- Revenue Growth
- -92.56%
- P/S Ratio
- 7.13
- Revenue/Employee
- EUR 54,062
- Employees
- 22
- Market Cap
- EUR 8.48M
Revenue Chart
Bioline RX Ltd Sponsored ADR Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.19M | -27.75M | -95.89% |
| Mar 31, 2025 | 28.94M | 24.14M | 502.92% |
| Dec 31, 2023 | 4.80M | 4.80M | ― |
| Dec 31, 2022 | 0.00 | 0.00 | ― |
| Dec 31, 2021 | 0.00 | 0.00 | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.